All stock lists
Unlock the score
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (Deutsche Börse:MUV2.DE)
DE · Delayed Price · Currency is EUR
Also listed: 0KFE.L, 0KFE.IL, MURGF, MUV2.SWFinancial Services · Insurance - Reinsurance
557.40+0.80 (+0.14%)
Market cap
$70.1B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 24, 1998
Website
Insider Score
/ 100
MUV2.DE Insider Score
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
MUV2.DE Stock Insider Trading Activity
MUV2.DE stock’s insider trading shows 7 purchases for an estimated $1.40M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days2 qualifying buys2 insiders$252.46K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Malherbe, Mari-Lizette Other | Buy | 196 | $509.00 | $115.91K | New | — | Aug 7, 2026 | C | Form 4 |
| Buchanan, Andrew Other | Buy | 300 | $509.00 | $177.42K | New | — | Aug 7, 2026 | B | Form 4 |
| Malherbe, Mari-Lizette Other | Buy | 413 | $478.89 | $229.80K | New | — | May 18, 2026 | BCluster Buy | Form 4 |
| Buchanan, Andrew Other | Buy | 370 | $466.83 | $200.69K | New | — | May 13, 2026 | BCluster Buy | Form 4 |
| Kassow, Dr. Achim Other | Buy | 300 | $470.00 | $163.82K | New | — | May 12, 2026 | BCluster BuyFirst Buy | Form 4 |
| Golling, Stefan Other | Buy | 420 | $476.19 | $232.37K | New | — | May 12, 2026 | BCluster BuyFirst Buy | Form 4 |
| Rieß, Dr. Markus Other | Buy | 500 | $476.50 | $276.81K | New | — | May 12, 2026 | BCluster BuyFirst Buy | Form 4 |
| Malherbe, Mari-Lizette Other | Buy | 377 | $528.60 | $231.54K | New | — | Mar 11, 2026 | B | Form 4 |
| Buchanan, Andrew Other | Buy | 230 | $550.40 | $147.08K | New | — | Feb 27, 2026 | BFirst Buy | Form 4 |
| Haidegger-Rieß, Nathalie Other | Sell | 898 | $520.27 | $542.82K | — | — | Jan 21, 2026 | — | Form 4 |
| Malherbe, Mari-Lizette Other | Buy | 380 | $520.40 | $229.76K | New | — | Jan 20, 2026 | B | Form 4 |
| Jäkel-Wickert, Julia Christiane Director | Buy | 95 | $526.80 | $58.15K | New | — | Jan 12, 2026 | BFirst Buy | Form 4 |
| Jurecka, Dr. Christoph Other | Buy | 600 | $542.60 | $378.26K | New | — | Nov 11, 2025 | B | Form 4 |
| Malherbe, Mari-Lizette Other | Buy | 371 | $535.00 | $230.61K | New | — | Nov 11, 2025 | BFirst Buy | Form 4 |
| Jurecka, Dr. Christoph Other | Buy | 600 | $519.80 | $362.36K | New | — | Sep 25, 2025 | BFirst Buy | Form 4 |
| Hervet ép. Kopff, Clarisse Other | Buy | 78 | $545.00 | $49.39K | New | — | Aug 26, 2025 | — | Form 4 |
| Hervet ép. Kopff, Clarisse Other | Buy | 6 | $545.00 | $3.80K | New | — | Aug 26, 2025 | — | Form 4 |
| Hervet ép. Kopff, Clarisse Other | Buy | 21 | $545.00 | $13.30K | New | — | Aug 26, 2025 | — | Form 4 |
| Hervet ép. Kopff, Clarisse Other | Buy | 1,695 | $545.00 | $1.07M | New | — | Aug 26, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.